Kartsogiannis V - Search Results

1

Characterization of sugar binding by osteoclast inhibitory lectin.

Gange CT, Quinn JM, Zhou H, Kartsogiannis V, Gillespie MT, Ng KW. Gange CT, et al. Among authors: kartsogiannis v. J Biol Chem. 2004 Jul 9;279(28):29043-9. doi: 10.1074/jbc.M312518200. Epub 2004 May 3. J Biol Chem. 2004. PMID: 15123656 Free article.

2

Osteoclast inhibitory lectin, a family of new osteoclast inhibitors.

Zhou H, Kartsogiannis V, Quinn JM, Ly C, Gange C, Elliott J, Ng KW, Gillespie MT. Zhou H, et al. Among authors: kartsogiannis v. J Biol Chem. 2002 Dec 13;277(50):48808-15. doi: 10.1074/jbc.M209059200. Epub 2002 Oct 8. J Biol Chem. 2002. PMID: 12374791 Free article.

3

Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.

Hu YS, Zhou H, Myers D, Quinn JM, Atkins GJ, Ly C, Gange C, Kartsogiannis V, Elliott J, Kostakis P, Zannettino AC, Cromer B, McKinstry WJ, Findlay DM, Gillespie MT, Ng KW. Hu YS, et al. Among authors: kartsogiannis v. J Bone Miner Res. 2004 Jan;19(1):89-99. doi: 10.1359/JBMR.0301215. J Bone Miner Res. 2004. PMID: 14753741 Free article.

4

Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.

Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM. Nakamura A, et al. Among authors: kartsogiannis v. Bone. 2007 Feb;40(2):305-15. doi: 10.1016/j.bone.2006.09.001. Epub 2006 Oct 13. Bone. 2007. PMID: 17049328

5

Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo.

Kartsogiannis V, Sims NA, Quinn JM, Ly C, Cipetic M, Poulton IJ, Walker EC, Saleh H, McGregor NE, Wallace ME, Smyth MJ, Martin TJ, Zhou H, Ng KW, Gillespie MT. Kartsogiannis V, et al. J Biol Chem. 2008 Nov 7;283(45):30850-60. doi: 10.1074/jbc.M801761200. Epub 2008 Sep 8. J Biol Chem. 2008. PMID: 18782774 Free PMC article.

6

A novel osteoblast-derived C-type lectin that inhibits osteoclast formation.

Zhou H, Kartsogiannis V, Hu YS, Elliott J, Quinn JM, McKinstry WJ, Gillespie MT, Ng KW. Zhou H, et al. Among authors: kartsogiannis v. J Biol Chem. 2001 May 4;276(18):14916-23. doi: 10.1074/jbc.M011554200. Epub 2001 Feb 13. J Biol Chem. 2001. PMID: 11278931 Free article.

7

Cell lines and primary cell cultures in the study of bone cell biology.

Kartsogiannis V, Ng KW. Kartsogiannis V, et al. Mol Cell Endocrinol. 2004 Dec 30;228(1-2):79-102. doi: 10.1016/j.mce.2003.06.002. Mol Cell Endocrinol. 2004. PMID: 15541574 Review.

8

Calcitonin receptor antibodies in the identification of osteoclasts.

Quinn JM, Morfis M, Lam MH, Elliott J, Kartsogiannis V, Williams ED, Gillespie MT, Martin TJ, Sexton PM. Quinn JM, et al. Among authors: kartsogiannis v. Bone. 1999 Jul;25(1):1-8. doi: 10.1016/s8756-3282(99)00094-0. Bone. 1999. PMID: 10423015

9

Activated T lymphocytes support osteoclast formation in vitro.

Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Horwood NJ, et al. Among authors: kartsogiannis v. Biochem Biophys Res Commun. 1999 Nov;265(1):144-50. doi: 10.1006/bbrc.1999.1623. Biochem Biophys Res Commun. 1999. PMID: 10548505

10

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT. Kartsogiannis V, et al. Bone. 1999 Nov;25(5):525-34. doi: 10.1016/s8756-3282(99)00214-8. Bone. 1999. PMID: 10574572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters